• Je něco špatně v tomto záznamu ?

Does the administration of antioxidants as scavengers of reactive oxygen species in kidney transplantation really have sense?

V Kuntscher, V Treska, J Racek, J Kobr, L Trefil, O Hes

. 2007 ; 108 (9) : 385-387.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10034943

Grantová podpora
NR7913 MZ0 CEP - Centrální evidence projektů

BACKGROUND: The aim of the study was to evaluate the degree of ischemia reperfusion syndrome (IRS) in serious ischemic insult of a kidney transplant and to try to mitigate the production of reactive oxygen substances (ROS) and inflammatory response. METHODS: The study was performed on 14 white pigs (20 kg). The pigs were divided in couples using a negative cross-matching and the couples were divided into the two groups. Each animal from the compatible couple was a donor/recipient of a kidney to/from the counterpart. Group II (TxII) received the intravenous antioxidants. Group I (TxI) was a control group. L-ascorbic acid 125 mg, selenium 4.4 mg, tocoferol 50 mg and N-acetyl-cysteine 200 mg were used as the antioxidants. They were applied intravenously to the TxII animals for 20 minutes before reperfusion of a kidney transplant. A serious ischemic insult was created by the left kidney hilum's cross-clamping for 30 min before donation. After the kidneys' removal, the left ones were flushed with Histidine Tryptophan Ketoglutarate (HTK) preservation solution and transplanted after the 1.5 hour (in the meantime stored in melted ice). Venous blood samples were taken for the assessment of malondialdehyde (MDA), reduced glutathione (GSH), glutathioneperoxidase (GSHPx), antioxidative capacity of plasma (AOC), interleukin 6 (IL-6), and tumor-necrosis factor alfa (TNFalfa) prior to the nefrectomy, before application of ROS scavengers (TxII), and during the 120-minute period after the transplantation (TxL+TxII). RESULTS: There wasn't a significant difference neither in production of MDA, nor in the levels of GSH, GSHPx, AOC, IL6 and TNFalfa between the TxI and TxII groups. CONCLUSIONS: Based on our results, we cannot conclude that the intravenous application of ROS scavengers in given combination and amount, administered to the recipient in the period just before transplantation, is a useful protective mechanism against kidney damage during IRS (Fig. 3, Ref. 17). Full Text (Free, PDF) www.bmj.sk.

000      
03643naa 2200397 a 4500
001      
bmc10034943
003      
CZ-PrNML
005      
20130919101329.0
008      
101221s2007 xo e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Kuntscher, Vilém, $d 1966- $7 xx0081969
245    10
$a Does the administration of antioxidants as scavengers of reactive oxygen species in kidney transplantation really have sense? / $c V Kuntscher, V Treska, J Racek, J Kobr, L Trefil, O Hes
314    __
$a Transplantation Centre, Medical Faculty Plzen, Charles University Prague, University Hospital Plzen, Czech Republic. kuntscher@fnplzen.cz
520    9_
$a BACKGROUND: The aim of the study was to evaluate the degree of ischemia reperfusion syndrome (IRS) in serious ischemic insult of a kidney transplant and to try to mitigate the production of reactive oxygen substances (ROS) and inflammatory response. METHODS: The study was performed on 14 white pigs (20 kg). The pigs were divided in couples using a negative cross-matching and the couples were divided into the two groups. Each animal from the compatible couple was a donor/recipient of a kidney to/from the counterpart. Group II (TxII) received the intravenous antioxidants. Group I (TxI) was a control group. L-ascorbic acid 125 mg, selenium 4.4 mg, tocoferol 50 mg and N-acetyl-cysteine 200 mg were used as the antioxidants. They were applied intravenously to the TxII animals for 20 minutes before reperfusion of a kidney transplant. A serious ischemic insult was created by the left kidney hilum's cross-clamping for 30 min before donation. After the kidneys' removal, the left ones were flushed with Histidine Tryptophan Ketoglutarate (HTK) preservation solution and transplanted after the 1.5 hour (in the meantime stored in melted ice). Venous blood samples were taken for the assessment of malondialdehyde (MDA), reduced glutathione (GSH), glutathioneperoxidase (GSHPx), antioxidative capacity of plasma (AOC), interleukin 6 (IL-6), and tumor-necrosis factor alfa (TNFalfa) prior to the nefrectomy, before application of ROS scavengers (TxII), and during the 120-minute period after the transplantation (TxL+TxII). RESULTS: There wasn't a significant difference neither in production of MDA, nor in the levels of GSH, GSHPx, AOC, IL6 and TNFalfa between the TxI and TxII groups. CONCLUSIONS: Based on our results, we cannot conclude that the intravenous application of ROS scavengers in given combination and amount, administered to the recipient in the period just before transplantation, is a useful protective mechanism against kidney damage during IRS (Fig. 3, Ref. 17). Full Text (Free, PDF) www.bmj.sk.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x aplikace a dávkování $7 D000975
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a scavengery volných radikálů $x aplikace a dávkování $x farmakologie $7 D016166
650    _2
$a intravenózní infuze $7 D007262
650    _2
$a transplantace ledvin $7 D016030
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a reperfuzní poškození $x metabolismus $x prevence a kontrola $7 D015427
650    _2
$a Sus scrofa $7 D034421
650    _2
$a financování organizované $7 D005381
700    1_
$a Třeška, Vladislav, $d 1957- $7 jn20000402436
700    1_
$a Racek, Jaroslav, $d 1951- $7 jn20000402090
700    1_
$a Kobr, Jiří, $d 1950- $7 xx0102261
700    1_
$a Trefil, Ladislav $7 xx0099653
700    1_
$a Hes, Ondřej, $d 1968- $7 jn20001103502
773    0_
$w MED00000845 $t Bratislavské lekárske listy $g Roč. 108, č. 9 (2007), s. 385-387 $x 0006-9248
910    __
$a ABA008 $b A 4 $y 7
990    __
$a 20110223130814 $b ABA008
991    __
$a 20130919101835 $b ABA008
999    __
$a ok $b bmc $g 823380 $s 688807
BAS    __
$a 3
BMC    __
$a 2007 $b 108 $c 9 $d 385-387 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
GRA    __
$a NR7913 $p MZ0
LZP    __
$a 2011-2B/ewme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...